STOCK TITAN

Establishment Labs director files Form 4 showing large sale and small purchase

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Lewin Nicholas Sheridan, identified as a director of Establishment Labs Holdings, filed a Form 4 dated 08/14/2025 reporting insider transactions in the company’s common stock. The filing shows a purchase of 2,600 common shares at $37.85 and separately lists a disposition of 1,075,923 common shares. Following the reported transactions, the Form 4 shows 19,090 shares beneficially owned, held indirectly. A footnote states the shares are held by the reporting person’s spouse. The Form was signed by the company’s CFO by power of attorney on 08/14/2025.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Form 4 reports a large disposition of 1,075,923 shares and a small purchase of 2,600 shares at $37.85; beneficial ownership is 19,090 shares.

The disclosure is factual and quantifies the insider activity: a purchase of 2,600 shares at $37.85 and a reported sale/Disposition of 1,075,923 shares. Beneficial ownership after the reported transactions is shown as 19,090 shares held indirectly, with a footnote that those shares are held by the reporting person’s spouse. The filing was executed by the CFO by power of attorney. As presented, this Form 4 is a routine Section 16 disclosure that documents significant movement in holdings but provides no explanation for the disposition.

TL;DR: Large reported disposition alongside a small purchase and spouse-held shares warrant attention, though the Form 4 itself is a standard disclosure.

The Form 4 clearly records both an acquisition (2,600 shares at $37.85) and a substantial disposition (1,075,923 shares). It also notes indirect ownership of 19,090 shares via the reporting person’s spouse. The document is signed by the CFO under power of attorney, which is an accepted administrative practice. The filing is material in size but contains no narrative explaining the transfer or timing beyond the dates shown.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LEWIN NICHOLAS SHERIDAN

(Last) (First) (Middle)
C/O MOTIVA USA LLC
16192 COASTAL HIGHWAY

(Street)
LEWES DE 19958

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ESTABLISHMENT LABS HOLDINGS INC. [ ESTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/14/2025 P 2,600 A $37.85 19,090 I See Footnote(1)
Common Shares 1,075,923 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares are held by the Reporting Person's spouse.
Remarks:
/s/ Rajbir S. Denhoy, Chief Financial Officer, by power of attorney 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Establishment Labs Hldgs Inc

NASDAQ:ESTA

ESTA Rankings

ESTA Latest News

ESTA Latest SEC Filings

ESTA Stock Data

2.22B
23.97M
10.74%
104.74%
17.69%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Costa Rica
ALAJUELA